Current Treatment Trends in Fabry Disease

被引：0
|
作者：
Linthorst, Gabor [1 ]
机构：
[1] Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands
来源：
CLINICAL THERAPEUTICS | 2009年 / 31卷
关键词：
ENZYME REPLACEMENT THERAPY; HUMAN ALPHA-GALACTOSIDASE; AGALSIDASE-BETA; TRIAL; EFFICACY; SAFETY;
D O I：
10.1016/S0149-2918(09)00245-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [1] Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
    Lenders, Malte
    Hennermann, Julia B.
    Kurschat, Christine
    Rolfs, Arndt
    Canaan-Kuehl, Sima
    Sommer, Claudia
    Ueceyler, Nurcan
    Kampmann, Christoph
    Karabul, Nesrin
    Giese, Anne-Katrin
    Duning, Thomas
    Stypmann, Joerg
    Kraemer, Johannes
    Weidemann, Frank
    Brand, Stefan-Martin
    Wanner, Christoph
    Brand, Eva
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [2] Fabry disease. Diagnosis and treatment
    Ueceyler, N.
    Sommer, C.
    SCHMERZ, 2012, 26 (05): : 609 - 618
  • [3] Treatment in Fabry disease
    Lopez Rodriguez, M.
    REVISTA CLINICA ESPANOLA, 2018, 218 (09): : 489 - 495
  • [4] Current and experimental therapeutics for Fabry disease
    Castelli, Vanessa
    Stamerra, Cosimo Andrea
    d'Angelo, Michele
    Cimini, Annamaria
    Ferri, Claudio
    CLINICAL GENETICS, 2021, 100 (03) : 239 - 247
  • [5] Migalastat for the treatment of Fabry disease
    Sunder-Plassmann, Gere
    Schiffmann, Raphael
    Nicholls, Kathleen
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (05): : 301 - 309
  • [6] Treatment of Fabry Disease: Current and Emerging Strategies
    Rozenfeld, Paula
    Neumann, Pablo M.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (06) : 916 - 922
  • [7] A revised home treatment algorithm for Fabry disease: Influence of antibody formation
    Smid, B. E.
    Hoogendijk, S. L.
    Wijburg, F. A.
    Hollak, C. E. M.
    Linthorst, G. E.
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : 132 - 137
  • [8] Long Term Treatment with Enzyme Replacement Therapy in Patients with Fabry Disease
    Oder, Daniel
    Nordbeck, Peter
    Wanner, Christoph
    NEPHRON, 2016, 134 (01) : 30 - 36
  • [9] Current and Investigational Therapeutics for Fabry Disease
    Felis, Andrew
    Whitlow, Michael
    Kraus, Abigayle
    Warnock, David G.
    Wallace, Eric
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (04): : 407 - 413
  • [10] Fabry Disease Therapy: State-of-the-Art and Current Challenges
    Azevedo, Olga
    Gago, Miguel Fernandes
    Miltenberger-Miltenyi, Gabriel
    Sousa, Nuno
    Cunha, Damiao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 16
12345